Property listed on Do-It-Yourself platform Homepie saves CA resident over 10% of selling price

Smart Home Sellers Save Tens of Thousands

SIMI VALLEY, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) — Homepie, Inc®, a leading provider of do-it-yourself tools for home sellers and buyers who wish to transact without a real estate agent, today announced that a Suisun City, CA resident sold her home on her own and saved more than 10% of the selling price of the home by listing on Homepie.com.

Homepie reports that Kelly Rohlfs originally met with a few REALTORS® about listing her home for sale. The highest price recommended by a REALTOR® she interviewed was $399,000. Kelly decided to list the home on Homepie, a commission-free for sale by homeowner site that provides all of the tools needed to buy or sell a home without a REALTOR®. Kelly listed her home for $419,000 to test the market. Her first offer fell out of escrow, however, her second offer came in at $426,500 – $27,500 above the Realtors recommended asking price. By not listing with a REALTOR®, Kelly avoided the traditional 6% commission fees, although not a requirement, she did agree to pay the buyer’s agent a 3% commission of about $13,000.

Homepie is an innovative technological response to the market’s strong demand for a space that enables home buyers and sellers to connect directly with each other in real-time. Kelly listed this investment property for sale from her home in Hawaii. The entire transaction was done remotely using digital transaction management tools and a transaction coordinator provided by Homepie. “In this seller’s market where homes are selling above list price for multiple offers, I don’t know why anyone would list with a REALTOR®,” says Kelly.

Kelly plans to sell another home using Homepie later this year.

“It’s very satisfying to see home buyers and sellers connecting on Homepie and saving thousands in equity that has traditionally been consumed by REALTOR® commissions,” says Brad Rice, CEO and Founder of Homepie. “Listing your home independently is certainly a bit more work than working with a REALTOR®, but homes are selling quickly in the current market with limited inventory. Additionally, fear of COVID along with the quarantine has caused traditional open house and showing services offered by REALTORS® to not be viable,” continued Rice. Homepie currently has 364 homes for sale with more being added daily. Proceeds from the purchase or sale of a home are maximized by avoiding the REALTOR® commission.

About Homepie
Homepie is the place where savvy consumers go for commission-free help to buy or sell homes. Listing a home on Homepie enables home sellers to easily remarket their listing across 100+ websites including the MLS, so that prospective buyers can be sure to find it. Additionally, a major problem that Homepie solved is simplifying the back-and-forth negotiation process for buyers and sellers. The online contract creation tool removes the guesswork around the paperwork. Today, more than 1 in 10 home sales already close directly between buyer and seller without a real estate agent. Now, with Homepie’s central online marketplace and a simple step-by-step process, anyone can do the same with confidence, and simplicity. Homepie has all the tools to list, market, search, view, offer, negotiate, and auto-generate a purchase agreement that is digitally signed. Best of all, it is 100% free to consumers, as the recommended service providers (photography, insurance, movers, etc.) cover the operating costs. Homepie takes the worry and guesswork out of home buying and selling. Learn how at homepie.com.

Media Contact:

Jules Penham
[email protected]
801-971-8446

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a8bc7b6f-c50e-424b-8a00-c0849e60f35b



Eloxx Pharmaceuticals to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference

WALTHAM, Mass., Nov. 18, 2020 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis and other diseases caused by nonsense mutations limiting production of functional proteins, is pleased to announce that Dr. Gregory Williams, Chief Executive Officer of Eloxx, will participate in a fireside chat and host one-on-one meetings with investors at the Piper Sandler 32nd Annual Virtual Growth Conference. The fireside chat will be available on the Piper Sandler Conference website to registered attendees on November 23rd at 10:00 AM ET to December 3, 2020.

The Company will host the one-on-one meetings with investors on Tuesday, December 1, 2020, meetings can be requested exclusively via Piper Sandler.

A replay of the fireside chat can be accessed under Events and Presentations in the Investors section of our website at https://investors.eloxxpharma.com/events-and-presentations.

Eloxx Pharmaceuticals

Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates (designed to be eukaryotic ribosomal selective glycosides) that are formulated to treat rare and ultra-rare premature stop codon diseases. Premature stop codons are point mutations that disrupt protein synthesis from messenger RNA. As a consequence, patients with premature stop codon diseases have reduced or eliminated protein production from the mutation bearing allele accounting for some of the most severe phenotypes in these genetic diseases. These premature stop codons have been identified in over 1,800 rare and ultra-rare diseases. Read-through therapeutic development is focused on extending mRNA half-life and increasing protein synthesis by enabling the cytoplasmic ribosome to read through premature stop codons to produce full-length proteins. Eloxx’s lead investigational product candidate, ELX-02, is a small molecule drug candidate designed to restore production of full-length functional proteins. ELX-02 is in the early stages of clinical development focusing on cystic fibrosis. ELX-02 is an investigational drug that has not been approved by any global regulatory body. Eloxx’s preclinical candidate pool consists of a library of novel drug candidates designed to be eukaryotic ribosomal selective glycosides identified based on read-through potential. Eloxx also has preclinical programs focused on kidney diseases including autosomal dominant polycystic kidney disease, as well as rare ocular genetic disorders. Eloxx is headquartered in Waltham, MA, with operations in Rehovot, Israel and Morristown, NJ. For more information, please visit www.eloxxpharma.com.

Forward-Looking Statements

This press release contains forward-looking statements, which are generally statements that are not historical facts. Forward-looking statements can be identified by the words “expects,” “anticipates,” “believes,” “intends,” “estimates,” “plans,” “will,” “outlook” and similar expressions. Forward-looking statements are based on management’s current plans, estimates, assumptions and projections, and speak only as of the date they are made. We undertake no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of factors,
including: the development of the Company’s read-through technology; the approval of the Company’s patent applications; the Company’s ability to successfully defend its intellectual property or obtain necessary licenses at a cost acceptable to the Company, if at all; the successful implementation of the Company’s research and development programs and collaborations; the Company’s ability to obtain applicable regulatory approvals for its current and future product candidates; the acceptance by the market of the Company’s products should they receive regulatory approval; the timing and success of the Company’s preliminary studies, preclinical research, clinical trials, and related regulatory filings; the ability of the Company to consummate additional financings as needed; the impact of global health concerns, such as the COVID-19 global pandemic, on our ability to continue our clinical and preclinical programs and otherwise operate our business effectively; as well as those
discussed in more detail in our Annual Report on Form 10-K and our other reports filed with the Securities and Exchange Commission.

Contact:

Barbara Ryan
203-274-2825

[email protected]

SOURCE: Eloxx Pharmaceuticals, Inc.



FRO – Invitation to Q3 2020 Results Conference Call and Webcast

Frontline Ltd.’s preliminary third quarter 2020 results will be released on Wednesday November 25 2020, and a webcast and conference call will be held at 3:00 p.m. CET (9:00 a.m. U.S. Eastern Time). The results presentation will be available for download from the Investor Relations section at www.frontline.bm ahead of the conference call.

In order to attend the conference call you may do one of the following:

a. Webcast
Go to the Investor Relations section at www.frontline.bm and follow the “Webcast” link.

b. Conference Call
Participant dial-in telephone numbers:

Norway +47 2103 3922
Norway toll free 800 10393
UK +44 (0) 203 009 5709
UK Toll Free 0 800 694 1461
USA +1 646 787 1226
USA Toll Free 866 280 1157
Conference ID 8429809

Participants will be asked for their full name & Conference ID.

A Q&A session will be held after the teleconference/webcast. Information on how to submit questions will be given at the beginning of the session.

The presentation material which will be used in the teleconference/webcast can be downloaded from www.frontline.bm.

Replay details (available for 7 days)

UK LocalCall 0 844 571 8951
UK FreeCall 0 808 238 0667
Std International +44 (0) 333 300 9785
Norway 21 03 42 35
USA +1 (917) 677-7532
USA Toll Free +1 (866) 331-1332
Conference ID 8429809

Participant information required: Full name & company

This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.



Anaplan Recognized as one of North America’s Fastest-Growing Companies on Deloitte’s 2020 Technology Fast 500™

Anaplan Recognized as one of North America’s Fastest-Growing Companies on Deloitte’s 2020 Technology Fast 500™

Attributes Revenue Growth to Demand for Rapid Scenario Modeling and Forecasting Capabilities, New Go-to-market Partnerships, and Innovative Intelligence Offerings

SAN FRANCISCO–(BUSINESS WIRE)–
Anaplan, Inc. (NYSE: PLAN), provider of a cloud-native platform for orchestrating business performance, today announced it has been included in Deloitte’s Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America now in its 26th year.

“We are honored to once again be recognized by Deloitte as one of North America’s fastest growing technology companies,” said Frank Calderoni, Chairman and CEO of Anaplan. “In a year of unparalleled disruption, business leaders have been tested by their ability to plan against a myriad of complex scenarios and make strategic decisions in an ever-evolving landscape. Anaplan has become mission critical for our customers, and we believe this recognition underscores our commitment to helping businesses build connected, forward-looking plans that incorporate market intelligence for more agile, confident decision making.”

“For more than 25 years, we’ve been honoring companies that define the cutting edge and this year’s Technology Fast 500 list is proof positive that technology — from software and digital media platforms, to biotech — truly does permeate so many facets of our lives,” said Paul Silverglate, vice chairman, Deloitte LLP and U.S. technology sector leader. “We congratulate this year’s winners, especially during a time when innovation is needed more than ever to address the monumental challenges posed by the pandemic.”

“Each year the Technology Fast 500 listing validates how important technology innovation is to our daily lives. It was interesting to see this year that while software companies continued to dominate, biotech companies rose to the top of the winners list for the first time, demonstrating that new categories of innovation are accelerating in the pursuit of making life easier, safer and more productive,” said Mohana Dissanayake, partner, Deloitte & Touche LLP, and industry leader for technology, media and telecommunications, within Deloitte’s audit and assurance practice. “We extend sincere congratulations to these well-deserved winners — who all embody a spirit of curiosity, and a never-ending commitment to making technology advancements possible.”

Overall, 2020 Technology Fast 500™ companies achieved revenue growth ranging from 175% to 106,508% from 2016 to 2019, with median growth of 450%.

About Deloitte’s 2020 Technology Fast 500™

Now in its 26th year, Deloitte’s Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences and energy tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2016 to 2019.

In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least $US50,000, and current-year operating revenues of at least $US5 million. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.

About Anaplan

Anaplan, Inc. (NYSE: PLAN) is a cloud-native enterprise SaaS company helping global enterprises orchestrate business performance. Leaders across industries rely on our platform—powered by our proprietary Hyperblock® technology—to connect teams, systems, and insights from across their organizations to continuously adapt to change, transform how they operate, and reinvent value creation. Based in San Francisco, Anaplan has over 20 offices globally, 175 partners and approximately 1,500 customers worldwide. To learn more, visit anaplan.com.

About Deloitte

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the “Deloitte” name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.

Caitlin Tridle

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Networks Internet Data Management Technology Software

MEDIA:

Eurofins Viracor Diagnostics Launches Combined Test For COVID-19, Influenza, And RSV As The Flu Season Approaches

The combined test offers an efficient and highly sensitive method to detect multiple respiratory pathogens including COVID-19 and Flu to inform treatment decisions

PR Newswire

LEE’S SUMMIT, Mo., Nov. 18, 2020 /PRNewswire/ — Eurofins Viracor, a leading infectious disease testing laboratory for more than 35 years, announces the launch  of several combined tests which detect COVID-19, influenza A/B, and respiratory syncytial virus (RSV). The combined SARS-CoV-2 Plus Flu A/B and RSV tests are intended for the qualitative detection of SARS-CoV-2 and the quantitative detection of Influenza A, Influenza B, and RSV.

With flu season underway and US COVID-19 cases reaching 10 million, these combined tests will play an important role for extended care facilities, employers, schools, and healthcare systems by distinguishing between multiple respiratory pathogens that exhibit overlapping symptoms including COVID-19 and Flu.

The combined COVID-19 and Flu test is now available and can also be ordered as individual tests. The combined COVID-19, Flu, and RSV test is anticipated to launch on December 7.

Since the onset of the pandemic, Eurofins Viracor has continued its leadership in the diagnostic testing effort to tackle this health crisis by being one of the first commercial laboratories to receive EUA of the SARS-CoV-2 RT-PCR test and continued capacity investment to support an average turnaround time of less than 24 hours. Eurofins Viracor’s innovative, highly accurate tests support healthcare systems, nursing homes, sports organizations, employers, and schools. Eurofins’ innovative COVID-19 assays include: EUA-authorized At-Home COVID-19 PCR Test Kit, pooled, antibody, wastewater, worn-mask, and saliva tests.

COVID-19 testing plays a critical role in therapeutics population surveillance, clinical trials, and forthcoming vaccination implementation. Eurofins continues to support the scientific community’s pursuit of new COVID-19 vaccines and therapeutics during discover, novel assay development, and throughout all phases of clinical trials.

ABOUT VIRACOR

With over 30 years of specialized expertise in infectious disease, immunology and allergy testing for immunocompromised and critical patients, Viracor Eurofins is committed to helping medical professionals, transplant teams, reference laboratories and biopharmaceutical companies get results faster, when it matters most. Viracor is passionate about delivering value to its clients by providing timely, actionable information, never losing sight of the connection between the testing it performs and the patients it ultimately serves. Viracor is a 100 percent subsidiary of Eurofins Scientific (EUFI.PA), the global leader in bio-analytical testing, and one of the world leaders in genomic services. For more information, please visit https://www.eurofins.com/ and https://www.viracor-eurofins.com/.

About Eurofins – the global leader in bio-analysis

Eurofins Scientific, through its subsidiaries (hereinafter “Eurofins” or “the Group”), believes it is the global leader in food, environmental, pharmaceutical and cosmetics products testing and in agroscience CRO services. It is also one of the global independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, CDMO, advanced material sciences and in the support of clinical studies. In addition, Eurofins is one of the leading global emerging players in esoteric and molecular clinical diagnostic testing. With over 50,000 staff across a network of more than 900 independent companies in over 50 countries generally specialised by end client markets and operating more than 800 laboratories, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of a wide range of products, as well as providing innovative clinical diagnostic testing services. The Group’s objective is to provide its customers with high-quality and innovative services, accurate results on time and, when requested, expert advice by its highly-qualified staff.

Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and a very large range of testing methods.

As one of the most innovative and quality-oriented international groups in its industry, Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the increasing demands of regulatory authorities and healthcare practitioners around the world.

Shares in Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/eurofins-viracor-diagnostics-launches-combined-test-for-covid-19-influenza-and-rsv-as-the-flu-season-approaches-301176184.html

SOURCE Viracor Eurofins

Access Announces Acquisition of Six U.S.-based Records and Information Management Companies

Expands presence in Milwaukee, WI; Boston, MA; Portland, OR; Beaumont, TX; Minneapolis, MN; and Los Angeles, CA

WOBURN, Mass., Nov. 18, 2020 (GLOBE NEWSWIRE) — Access, the world’s largest privately-held integrated information management services provider, today announced the completion of six U.S. acquisitions, including Hansen Records Management (Milwaukee, Wisconsin); SafeGuard Destruction (Boston, Massachusetts); the records storage business of DataSafe, Inc. (Portland, Oregon); PRIMCO (Beaumont, Texas); Insight Storage Solutions (Minneapolis, MN); and the records storage business of Beverly Hills Transfer & Storage (Los Angeles, CA).

With these acquisitions, Access significantly increases its share of the U.S. regional records and document storage markets while growing its customer base and expanding its service offerings and geographic reach.

“We continue to grow and expand geographically in 2020 and have completed six strategic acquisitions, despite the added challenges of this global pandemic,” said Jordan Peace, Vice President of Corporate Development at Access. “By broadening our presence in key cities including Milwaukee, Portland, Beaumont, Minneapolis, Los Angeles, and in our headquarters’ city of Boston, we are supporting our ongoing commitment to expand our services locally while managing information with the very best service worldwide.”

Today’s announcement builds on the business momentum started earlier this year with the following acquisitions announced in June: International Data Depository (Miami, Florida); Off-Site Records Management Inc. (Lexington, Kentucky); and the records storage business of ImageFreeway Inc. (Atlanta, Georgia).

The Access team is led by CEO Rob Alston and President John Chendo, two veterans of the records management industry. They have built a dynamic and well-respected company based on a strategic acquisition program and a focus on driving organic growth.   New capabilities include software offerings Virgo – for retention and privacy compliance; and CartaHR, CartaDC, and CartaDC Essentials – cloud-based document management solutions that help companies focus on security, compliance and efficiency.

About Access
:


Access
 is the largest privately-held records and information management services provider worldwide, with operations across the United States, Canada, Central America and South America. Access provides transformative services, expertise and technologies to make organizations more efficient and more compliant. Access helps companies manage and activate their critical business information through offsite storage and information governance services, scanning and digital transformation solutions, document management software and secure destruction services. For 11 consecutive years, Access has been named to the Inc. 5000, the ranking of fastest-growing private companies in the U.S. For more information on Access, please visit AccessCorp.com.

For more information, contact:

Company Contact:

Melissa Kolodziej
781-710-0763
[email protected]

Media Contact:
Lisa Hendrickson/LCH Communications for Access
516-767-8390
[email protected]



SmartCard Marketing Systems Inc. (OTC:SMKG) Portfolio Owned Marketplaces Enabling E-commerce and Mobility Payments to Lead Next Wave of Growth Across Multiple Industries Globally

SMKG Digital Strategy does much more than simply enable shopping experiences and payment rails; the company enables community marketplaces to seamlessly transact and improve “the customer journey and experience”

New York, NY, Nov. 18, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — SmartCard Marketing Systems Inc. (OTC:SMKG): The company’s Intellectual Property of sixteen proprietary Cloud and Mobility marketplace platforms enable end-to-end ecosystems for E-commerce & Mobility experiences by enabling merchants and consumers in one community. The Industries include Retail, Restaurant, Events, Hotel, Hospitality, Catering, Workforce, Transit, Travel, Agriculture, Cross-Border FX, Banking, Insurance, HealthCare, Education, Tele-medicine & Telecom. All the SMKG platforms seamlessly offer Contactless Payment architectures from various Card Networks like Visa, Apple Pay, Google Pay, Axepay and over 35 global payment gateways and processors globally. In addition, we offer MPOS EMV semi-integrated solutions for card-present transactions that complete the experience.


Industry Trends and Stats

“Online B2B sellers and marketers will move toward more widespread use of a new breed of online marketplaces and more flexible digital commerce and marketing operations, Forrester Research says in a new series of reports.” Source: https://www.digitalcommerce360.com/2019/11/11/2020-b2b-predictions-a-fresh-take-on-marketplaces-and-innovation/

“1. The importance of marketplaces continues to grow

First things first: The growing importance of marketplaces can’t be understated.

Yes, companies like Uber struggle with turning a positive cash flow. But if you look at global marketplace trends, you quickly see that marketplace businesses are here to stay.

Every year, the 18 biggest marketplaces sell $1 trillion worth of goods. And by 2020, marketplaces will account for 40% of the global online retail market.

Not only that,12% of major retailers operate a marketplace. 32% are considering opening one.

After all, marketplaces offer convenience and trust to customers. No wonder a marketplace like Amazon is the most valuable public company in the world.” 


Source:
 https://www.kreezalid.com/blog/78470-marketplace-trends

Massimo Barone, CEO, stated, “We are excited to see a wide acceptance of our platforms as our long-term focus and investment on Marketplace technologies is the largest available proprietary portfolio for Cloud and Mobility applications by one company in the FinTech & PayTech sector.

“This strategy maximizes growth and shareholder value as we license and partner with Banks, Governments and Enterprises for Fintech and PayTech initiatives such as the Mumbai Fintech Hub deal announced recently – all this combined which allows us to capture large pools of merchants and customers activations which is driving already 7 White-label deployments underway in North America, Caribbean, Philippines and India, with more in the works!”

About us

SmartCard Marketing Systems Inc (OTC:SMKG) is an industry leader in specialized industry cloud and mobility applications to the global PayTech and FinTech markets. SMKG is an entrepreneurial boutique technology company, providing business intelligence and digital transformation strategies with a proprietary portfolio of applications and wireframes for banking, enterprises, retail e-wallets, digital id-eKYC, digital workforce, events management, education, telemedicine and ride-booking industries. For more info visit www.smartcardmarketingsystems.com or visit our business applications marketplace at www.Emphasispay.com.

We seek a safe harbor.

CONTACT:  Massimo Barone CEO
[email protected]
SmartCard Marketing Systems Inc.
OTC:SMKG  Ph: 1-844-843-7296
[email protected]



Religious Liberty Firm Urges U.S. Supreme Court to Protect Places of Worship from NY Governor Cuomo’s Order

First Liberty Institute files friend-of-the-court brief in key religious liberty case at the Supreme Court of the United States

WASHINGTON, Nov. 18, 2020 (GLOBE NEWSWIRE) — First Liberty Institute filed a friend-of-the-court brief in The Roman Catholic Diocese of Brooklyn v. Cuomo, a case in which the Brooklyn Diocese has asked the Supreme Court of the United States to grant an emergency injunction against restrictions on houses of worship ordered by New York Governor Andrew Cuomo.

You can read the brief here.

“Governor Cuomo’s orders unlawfully target religious worship and violate the First Amendment,” said Stephanie Taub, Senior Counsel for First Liberty Institute. “Courts must be vigilant to protect fundamental individual liberties for all Americans, especially during a time of crisis. Courts must meaningfully review any order that singles out religious worship as a category for its own unique and burdensome restrictions.”
  
Governor Cuomo’s latest Executive Order imposes restrictions on houses of worship while favoring well over one hundred secular, for-profit activities over religiously-motivated activities.  Attendance at houses of worship is capped at 10 or 25 people in certain areas, while a wide range of for-profit activity in these areas are not subject to any capacity limitations at all.  In response, the Brooklyn Diocese argues the COVID-19 restrictions imposed by Governor Cuomo violate its constitutional right of religious freedom.

In its brief, First Liberty urged the Supreme Court to grant the emergency injunction “to correct lower courts’ widespread misinterpretation” of its opinion in South Bay United Pentecostal Church v. Newsom issued earlier this year. 

“Lower courts across the country are misconstruing the [South Bay] opinion to hold that normal principles of constitutional law do not apply during a prolonged pandemic. Courts have granted an unprecedented level of deference to government officials to impose unequal and discriminatory restrictions on religious exercise, functionally holding that decades of religious liberty precedents are indefinitely on hold. South Bay, of course, stands for no such thing.”

About First Liberty Institute

First Liberty Institute is the largest legal organization in the nation dedicated exclusively to defending religious freedom for all Americans.

To arrange an interview, contact Lacey McNiel at [email protected] or by calling 972-941-4453.

Contact: Lacey McNiel, [email protected]
Direct: 972-941-4453



Arrival, the company creating electric vehicles with its game-changing technologies, to list on NASDAQ through merger with CIIG Merger Corp.

  • Arrival, the company creating electric vehicles (“EVs”) with its game-changing technologies, has entered into a definitive business combination agreement with CIIG Merger Corp. (NASDAQ: CIIC); and the newly combined company will be listed on the NASDAQ under the new ticker symbol “ARVL”
  • The transaction values the combined company at an enterprise value of US $5.4 billion and is expected to provide approximately US $660 million in gross cash proceeds to the Company. As part of the transaction, CIIG raised a US $400 million fully committed common stock PIPE that was anchored by Fidelity Management & Research Company LLC, Wellington Management, BNP Paribas Asset Management Energy Transition Fund, and funds and accounts managed by BlackRock
  • Arrival is producing EVs competitive in price with fossil fuel alternatives and substantially lower than comparable EVs
  • Arrival has developed a new method of designing and producing zero-emission vehicles using its proprietary hardware, software and robotics technologies and low cost Microfactories
  • Arrival has signed contracts with total order value up to US $1.2 billion and its first products are planned for production in Q4 2021
  • Arrival has previously received investment from strategic partners Hyundai, Kia, UPS, Winter Capital, and funds and accounts managed by BlackRock
  • The combined company will add Peter Cuneo, CIIG’s Chairman and CEO, as Non-Executive Chairman to its post-closing Board of Directors

NEW YORK and LONDON, Nov. 18, 2020 (GLOBE NEWSWIRE) — Arrival, the company creating electric vehicles (“EVs”) with its game-changing technologies, and CIIG Merger Corp. (NASDAQ: CIIC), a US publicly-traded special purpose acquisition company, today announced they have entered a definitive agreement for a business combination. Upon closing of the transaction, the combined company will be named Arrival Group and is expected to be listed on NASDAQ under the new ticker symbol “ARVL”.

Company Highlights

Arrival is challenging the 100 year old automotive production process, by producing its EVs in low CapEx, low footprint Microfactories. Its operations utilize Arrival’s in-house proprietary technologies and advanced cell-based assembly method to bring down the cost of EVs and accelerate mass adoption globally.

Arrival’s initial focus is on the commercial vehicle market, which is undergoing a seismic shift towards electrification in line with global public policy. Arrival believes that it is well positioned to capitalize on this market opportunity with its technology driven approach to a traditionally underserved market. The result is its best-in-class products with an exceptional user experience that are priced competitively with fossil-fuel vehicles and have a substantially lower total cost of ownership (“TCO”) than both fossil fuel and electric variants.

Arrival’s transformative Microfactories can be deployed anywhere in the world within six months, using existing warehouses close to areas of demand. These Microfactories are designed to produce any vehicle from Arrival’s portfolio customized for the cities and regions they serve. The vehicles are designed specifically for Microfactory assembly using Arrival’s proprietary in-house developed components, software and sustainable composite materials.

Arrival’s vertical integration and new method of production break the rule of economies of scale and create strong unit economics for the whole Arrival product portfolio, which Arrival expects will enable profitability for the business by 2023. Arrival’s strategy to reach industry-transforming flexibility and scalability is based on the utilization of Microfactories, as opposed to giant, capital-intensive legacy factories.

“With Arrival’s products our clients are not forced to compromise between being green and being cost efficient. Our focus on the whole EV ecosystem, new methods of design and production and our enabling technologies are the key to driving down the cost of EVs and accelerating the transition to zero-emission transportation globally,” said Denis Sverdlov, Founder and CEO of Arrival. “CIIG’s leadership team has invaluable experience building businesses globally across a wide range of industries. We are excited to partner with them as we begin our journey to being a publicly-listed company and delivering our products to customers and cities around the world.”

“Arrival’s bold, game-changing approach to the production of electric vehicles made the company the clear winner in our search for a partner,” said Peter Cuneo, Chairman and CEO of CIIG. “Operating in stealth mode for five years, Denis and his visionary team have rewritten the rules of the game for the auto industry. Arrival’s development of exceptional products using its pioneering technology and software alongside its groundbreaking new method of production can create an incredibly low TCO for customers which we believe stands them apart from everyone else in the electric vehicle industry. We look excitedly to the future and to our partnership with Arrival’s talented leadership team.”

Several blue chip companies and investment firms have invested in Arrival, including Hyundai Motor Company, Kia Motors Corporation, Winter Capital, United Parcel Service (“UPS”) and funds and accounts managed by BlackRock. Hyundai and Kia are also exploring opportunities to co-develop zero-emission vehicles with Arrival.

In addition, alongside an investment in Arrival in early 2020, UPS, the global logistics company, announced a commitment to purchase 10,000 electric vans, and has the additional option to order more thereafter.

Successful technology entrepreneur Denis Sverdlov will remain as Arrival’s CEO, with ex-Cruise Head of Strategy, Avinash Rugoobur, continuing as Arrival’s President. Mike Ableson, former VP of Global Strategy at GM, is CEO of Arrival Automotive overseeing global production.

Transaction Overview

The transaction values the combined company at an enterprise value of US $5.4 billion. Pursuant to the merger and following the share exchanges, the combined company is expected to receive approximately US $660 million in gross cash proceeds from a combination of cash from a US $400 million fully committed stock PIPE and US $260 million in cash held in CIIG’s trust account, assuming no public shareholders exercise their redemption rights at closing. Net cash from the transaction will be used to fund growth of the combined company. The PIPE is anchored by institutional investors including funds and accounts managed by BlackRock, Fidelity Management & Research Company LLC, Wellington Management and BNP Paribas Asset Management Energy Transition Fund. Current Arrival shareholders will become the majority owners of the combined company at closing. All existing shareholders and investors will continue to hold their equity ownership, including, Hyundai Motor Company, Kia Motors Company, Winter Capital, UPS and funds and accounts managed by BlackRock.

Both the board of managers and shareholders of Arrival have unanimously approved the proposed transaction, which is expected to be completed in the first quarter of 2021. The board of directors of CIIG has also unanimously approved the proposed transaction. The proposed transaction will be subject to approval by CIIG stockholders and satisfaction or the waiver of the closing conditions identified in the business combination agreement.

Additional information about the proposed transaction, including a copy of the business combination agreement will be filed by CIIG in a Current Report on Form 8-K to be filed by CIIG with the Securities and Exchange Commission and available at www.sec.gov.

Advisors

Cowen served as lead placement agent and UBS Investment Bank served as placement agent on the PIPE. Cowen is serving as lead financial advisor and J.P. Morgan is serving as financial advisor to Arrival. UBS Investment Bank and Barclays are serving as financial and capital markets advisors to CIIG. Greenberg Traurig, LLP is serving as legal advisor to Arrival. Akin Gump Strauss Hauer & Feld LLP is serving as legal advisor to CIIG.

Investor Conference Call Information

Arrival and CIIG will host a joint investor call to discuss the proposed transaction and review an investor presentation today, November 18, 2020.

The investor presentation is furnished as an exhibit in a Current Report on Form 8-K filed by CIIG prior to the call, available on the SEC website at www.sec.gov.

To access the audio replay, go to Arrival’s investor website, at https://arrival.com/investors through November 30, 2020.

About Arrival

Arrival is reinventing the automotive industry with its entirely new approach to the design and assembly of electric vehicles. Low CapEx, rapidly scalable Microfactories combined with proprietary in-house developed components, materials and software, enable the production of best in class vehicles competitively priced to fossil fuel variants and with a substantially lower Total Cost of Ownership. This transformative approach provides cities globally with the solutions they need to create sustainable urban environments and exceptional experiences for their citizens. Arrival was founded in 2015 and is headquartered in the United Kingdom, with over 1,300 global employees located in offices across the United States, Germany, Netherlands, Israel, Russia, and Luxembourg. The company is deploying its first two Microfactories in South Carolina, US and Bicester, UK in 2021.

About CIIG

CIIG Merger Corp. (NASDAQ: CIIC) is a Delaware special purpose acquisition company founded by Peter Cuneo, Gavin Cuneo and Michael Minnick for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. CIIG’s units, Class A common stock and warrants trade on the NASDAQ under the ticker symbols “CIICU,” “CIIC,” and “CIICW” respectively.

Additional Information and Where to Find It

In connection with the proposed transaction, Arrival Group, a subsidiary of Arrival that will become the holding company of CIIG and be renamed Arrival as of the closing of the proposed transaction, is expected to file a registration statement on Form F-4 (the “Form F-4”) with the U.S. Securities and Exchange Commission (the “SEC”) that will include a proxy statement of CIIG that will also constitute a prospectus of Arrival Group. CIIG and Arrival Group urge investors, stockholders and other interested persons to read, when available, the Form F-4, including the preliminary proxy statement/prospectus and amendments thereto and the definitive proxy statement/prospectus and documents incorporated by reference therein, as well as other documents filed with the SEC in connection with the proposed transaction, as these materials will contain important information about Arrival Group, Arrival, CIIG and the proposed transaction. Such persons can also read CIIG’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, for a description of the security holdings of CIIG’s officers and directors and their respective interests as security holders in the consummation of the proposed transaction. When available, the definitive proxy statement/prospectus will be mailed to CIIG’s and Arrival’s stockholders. Stockholders will also be able to obtain copies of such documents, without charge, once available, at the SEC’s website at www.sec.gov, or by directing a request to: CIIG Merger Corp., 40 West 57th Street, 29th Floor, New York, NY 10019 or Arrival S.à r.l., 1, rue Peternelchen, L-2370 Howald, Luxembourg.

Participants in Solicitation

CIIG, Arrival Group and Arrival and their respective directors, executive officers and other members of their management and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies of CIIG’s stockholders in connection with the proposed transaction. Investors and security holders may obtain more detailed information regarding the names, affiliations and interests of CIIG’s directors and executive officers in CIIG’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, which was filed with the SEC on March 27, 2020. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies of CIIG’s stockholders in connection with the proposed transaction will be set forth in the proxy statement/prospectus for the proposed transaction when available. Information concerning the interests of CIIG’s participants in the solicitation, which may, in some cases, be different than those of CIIG’s equity holders generally, will be set forth in the proxy statement/prospectus relating to the proposed transaction when it becomes available.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the federal securities laws, including statements regarding the benefits of the proposed transaction, the anticipated timing of the proposed transaction, the products offered by Arrival and the markets in which it operates, and Arrival Group’s projected future results. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Such statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and are based on management’s belief or interpretation of information currently available. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including, but not limited to: (i) the risk that the transaction may not be completed in a timely manner or at all, which may adversely affect the price of CIIG’s securities, (ii) the risk that the transaction may not be completed by CIIG’s business combination deadline and the potential failure to obtain an extension of the business combination deadline if sought by CIIG, (iii) the failure to satisfy the conditions to the consummation of the transaction, including the adoption of the business combination agreement by the stockholders of CIIG and Arrival, the satisfaction of the minimum trust account amount following redemptions by CIIG’s public stockholders and the receipt of certain governmental and regulatory approvals, (iv) the lack of a third party valuation in determining whether or not to pursue the proposed transaction, (v) the occurrence of any event, change or other circumstance that could give rise to the termination of the business combination agreement, (vi) the impact of COVID-19 on Arrival’s business and/or the ability of the parties to complete the proposed transaction; (vii) the effect of the announcement or pendency of the transaction on Arrival’s business relationships, performance, and business generally, (viii) risks that the proposed transaction disrupts current plans and operations of Arrival and potential difficulties in Arrival employee retention as a result of the proposed transaction, (ix) the outcome of any legal proceedings that may be instituted against Arrival Group, Arrival or CIIG related to the business combination agreement or the proposed transaction, (x) the ability to maintain the listing of CIIG’s securities on the NASDAQ Stock Market, (xi) the price of CIIG’s and the post-combination company’s securities may be volatile due to a variety of factors, including changes in the competitive and highly regulated industries in which Arrival operates, variations in performance across competitors, changes in laws and regulations affecting Arrival business and changes in the combined capital structure, (xii) the ability to implement business plans, forecasts, and other expectations after the completion of the proposed transaction, and identify and realize additional opportunities, (xiii) the risk of downturns and the possibility of rapid change in the highly competitive industry in which Arrival operates, (xiv) the risk that Arrival and its current and future collaborators are unable to successfully develop and commercialize Arrival’s products or services, or experience significant delays in doing so, (xv) the risk that the post-combination company may never achieve or sustain profitability; (xvi) the risk that the post-combination company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; (xvii) the risk that the post-combination company experiences difficulties in managing its growth and expanding operations, (xviii) the risk that third-parties suppliers and manufacturers are not able to fully and timely meet their obligations; (xix) the risk that the utilization of Microfactories will not provide the expected benefits due to, among other things, the inability to locate appropriate buildings to use as Microfactories, Microfactories needing a larger than anticipated factory footprint, and the inability of Arrival to deploy Microfactories in the anticipated time frame; (xx) the risk that the orders that have been placed for vehicles, including the order from UPS, are cancelled or modified; (xxi) the risk of product liability or regulatory lawsuits or proceedings relating to Arrival’s products and services; (xxii) the risk that Arrival is unable to secure or protect its intellectual property; and (xxiii) the risk that the post-combination company’s securities will not be approved for listing on the NASDAQ Stock Market or if approved, maintain the listing. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of CIIG’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, the registration statement on Form F-4 and proxy statement/prospectus discussed above and other documents filed by CIIG from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Arrival Group, Arrival and CIIG assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Neither Arrival Group, Arrival nor CIIG gives any assurance that either Arrival Group, Arrival or CIIG will achieve its expectations.

No Offer or Solicitation

This press release is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed transaction and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of CIIG, Arrival or Arrival Group, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, or exemptions therefrom.

PRIIPs / Prospectus Regulation /IMPORTANT – EEA AND UK RETAIL INVESTORS – The ordinary shares to be issued by Arrival Group in the proposed transaction (the “Ordinary Shares”) are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the EEA or in the UK. For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of MiFID II; or (ii) a customer within the meaning of Directive (EU) 2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017
(this Regulation together with any implementing measures in any member state, the “Prospectus Regulation”). Consequently, no offer of securities to which this announcement relates, is made to any person in any Member State of the EEA which applies the Prospectus Regulation who are not qualified investors for the purposes of the Prospectus Regulation, is made in the EEA and no key information document required by Regulation (EU) No. 1286/2014 (as amended the “PRIIPs Regulation”) for offering or selling the Ordinary Shares or otherwise making them available to retail investors in the EEA or in the United Kingdom will be prepared and therefore offering or selling the Ordinary Shares or otherwise making them available to any retail investor in the EEA or in the United Kingdom may be unlawful under the PRIIPs Regulation.


Media Contacts

For Arrival

Media
Victoria Tomlinson
[email protected]

Investors
[email protected]

For CIIG

Media and Investors
Gavin Cuneo
[email protected]



Institutional Investor Ranks Five9 CEO, CFO and Investor Relations #1 in All-America Executive Team 2021 Midcap in 6 of the 8 Ranked Categories

Institutional Investor Ranks Five9 CEO, CFO and Investor Relations #1 in AllAmerica Executive Team 2021 Midcap in 6 of the 8 Ranked Categories

SAN RAMON, Calif.–(BUSINESS WIRE)–
Five9, Inc (NASDAQ: FIVN), a leading provider of the intelligent cloud contact center, today announced its executive and investor relations leadership were named to Institutional Investor’s prestigious 2021 All-America Executive Team Midcap.

Overall ranking in software sector:

  • “Best CEO” category: Ranked 1st – Rowan Trollope, Five9 CEO
  • “Best CFO” category: Ranked 1st – Barry Zwarenstein, Five9 CFO
  • “Best Investor Relations” category: Ranked 1st – Five9
  • “Investor Day” category: Ranked 1st – Five9
  • “Financially Material ESG Disclosures” category: Ranked 1st – Five9
  • “Communication of Strategy and Risk Management Amid COVID-19″ category: Ranked 1st – Five9

Institutional Investor is the industry’s most trusted source for research and rankings among top analysts and portfolio managers. For the 2021 ranking, the company collected the opinions of 1,125 portfolio managers and buy-side analysts and 257 sell-side analysts.

“We are honored to be recognized in Institutional Investor’s annual executive study as the top-ranking company in not just one but six of the listed categories,” said Rowan Trollope, Five9 CEO. “This is a true testament to the work and due diligence of our Five9 investor relations team guided by our trusted CFO, Barry Zwarenstein. Thank you to our investors and the sell-side community for this acknowledgement.”

About Five9

Five9 is an industry-leading provider of cloud contact center solutions, bringing the power of cloud innovation to more than 2,000 customers worldwide and facilitating more than six billion call minutes annually. The Five9 Intelligent Cloud Contact Center provides digital engagement, analytics, workflow automation, workforce optimization, and practical AI to create more human customer experiences, to engage and empower agents, and deliver tangible business results. Designed to be reliable, secure, compliant, and scalable, the Five9 platform helps contact centers increase productivity, be agile, boost revenue, and create customer trust and loyalty.

For more information, visit www.five9.com.

Five9

Kendall Taylor

925-231-2196

[email protected]

 

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Software Technology Other Technology

MEDIA:

Logo
Logo